Pain Management Drugs & Devices: Global Industry Outlook to 2023 - Growing Healthcare Market & Rapid Technological Developments - ResearchAndMarkets.com

DUBLIN--()--The "Pain Management Drugs and Devices - Global Market Outlook (2017-2023)" report has been added to ResearchAndMarkets.com's offering.

The Global Pain Management Drugs and Devices Market accounted for $41.73 billion in 2016 and is expected to reach $61.52 billion by 2023 growing at a CAGR of 5.7% during the forecast period.

Growing healthcare industry across the globe, rapid technological developments and increasing various pain disorders tied with rising global geriatric people are some of the key factors propelling the market growth. However, factors such as availability of alternative therapies, drug abuse and patent expiration of prescription drugs are hindering the market.

What the report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and Recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Segments Covered

Device Types

  • Neuromodulation Devices
  • Analgesic Infusion Pumps
  • Ablation Devices
  • Electrical stimulation devices

Drug Classes

  • Non-Narcotic Analgesics
  • Narcotic Pain Management
  • Opioids
  • Antidepressent
  • Anesthetics
  • NSAIDS
  • Anticovulsants
  • Anti-Migraine Agents
  • Other Drug Classes

Applications

  • General Pain
  • Dental Pain
  • HIV/AIDS Pain
  • Migraine Pain
  • Orthopedic/Musculoskeletal Pain
  • Neuropathic Pain
  • Cancer Pain
  • Fibromyalgia Pain
  • Surgical Pain
  • Other Applications

Indications

  • Arthritic Pain
  • Chronic back pain

Mode of Purchases

  • Over-the-counter Devices
  • Prescription-based Devices

Companies Profiled

  • Abbott Laboratories
  • Endo International
  • Abbvie
  • DJO Global Inc.
  • Johnson & Johnson
  • Novartis International AG
  • Grunenthal Gmbh
  • ELI Lilly & Co.
  • Hisamitsu Pharmaceutical Co. Inc.
  • Pfizer Inc.
  • Astrazeneca Plc
  • Purdue Pharma LP
  • GlaxoSmithKline
  • Medtronic
  • Boston Scientific Corp

For more information about this report visit https://www.researchandmarkets.com/research/2rp5ck/pain_management?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices, Analgesics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices, Analgesics